Dr. Juan Diego Cedeno, MD

Dr. Cedeno practices at Baptist Health Homestead Hospital in Homestead, Florida, part of Baptist Health South Florida.

Dr. Cedeno's NPI, 1043665177, was assigned on April 26, 2016. Dr. Cedeno graduated from Other in 2008. Dr. Cedeno holds Florida license 152676.

Dr. Cedeno's primary practice is Baptist Health Homestead Hospital, at 975 Baptist Way, Homestead, FL 33033 in Miami-Dade County. The practice phone is (786) 243-8000.

Dr. Cedeno's primary practice is Baptist Health Homestead Hospital in Homestead, Florida, part of Baptist Health South Florida. Dr. Cedeno is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Cedeno to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cedeno practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cedeno's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cedeno is board certified in urology by the American Board of Urology. Dmand AI has Dr. Cedeno's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Cedeno treats.

CMS data shows 335 Medicare services from Dr. Cedeno across 7 procedure codes in 2024, for 176 Medicare patients. Medicare paid $32,976 for them.

CMS counts 176 Medicare patients who saw Dr. Cedeno in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cedeno's median patient age at 62, with 31% women.

In 2024, Dr. Cedeno wrote 1,247 Medicare Part D claims for 343 patients. 55% of them were for generic drugs. CMS names the drug for 1,159 of them, across 21 drugs with 11 or more claims each, at $341,419 in total drug cost. In 2023, CMS named 767 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Cedeno for performance year 2024, reported through an alternative payment model (APM). Dr. Cedeno accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Cedeno, published from 2022 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Gender-Affirming Surgery, Postoperative Complications and Surgical Flaps. Dr. Cedeno has published most often in Neurourol Urodyn. Dr. Cedeno's most frequent co-authors are Omer Acar, MD, Ervin Kocjancic, MD and Ramsy Assaf Abdelghani, MD.

CMS Open Payments shows 175 general payments to Dr. Cedeno from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $4,002.

Dr. Cedeno graduated from Other in 2008.

Dr. Cedeno is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.